NVO
Novo Nordisk A/S
NVO trails on the overall score without a compensating advantage in the available component scores.
WRBY
Warby Parker Inc.
WRBY has the edge over NVO overall, supported by stronger fundamentals and stronger modeled upside.
NVO Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Healthy |
NVO's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
WRBY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Under pressure | |
| Strong |
WRBY's revenue, profitability and balance sheet are currently healthy, but its cash flow is under pressure.
NVO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 10x | $40.65 | — |
| Cheap | 14x | $53.56 | +32% |
| Fair | 27x | $103 | +154% |
| Expensive | 39x | $152 | +273% |
Historical ranges are pointers, not guarantees.
NVO has the edge over WRBY in the historical PE scenario, which offers more potential upside but is not a forecast.
WRBY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 53x | $26.73 | — |
| Cheap | 439x | $21.93 | -18% |
| Current | 535x | $26.73 | — |
| Fair | 2,274x | $114 | +325% |
| Expensive | 2,646x | $132 | +395% |
Historical ranges are pointers, not guarantees.
WRBY's PE is in its cheap range at 535x. If earnings grow as analysts expect, today's price would be 53x next year's earnings.
NVO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Stable | |
| Growth | |
| Weakening | |
| Limited | |
| Low |
Analysts expect NVO's revenue to grow, but its profitability to weaken. However, they disagree widely on these estimates.
WRBY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Improving | |
| Limited | |
| Low |
WRBY has the edge over NVO on the outlook, with more favorable earnings and profitability expectations.
NVO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $3.89 | +4.9% |
| Q1 2026 | $4.07 | +17% |
| Q4 2025 | $3.42 | +1.8% |
| Q3 2025 | $3.47 | +10% |
| Q2 2025 | $3.71 | +24% |
| Q1 2025 | $3.49 | +18% |
| Q4 2024 | $3.36 | +21% |
| Q3 2024 | $3.15 | +27% |
NVO's earnings per share have climbed steadily: $3.89 over the past year, up 4.9% from the year before, and higher year over year every quarter since late 2020.
WRBY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.51 | +916% |
| Q3 2026 | $0.05 | +400% |
| Q2 2026 | $0.06 | +$0.13 |
| Q1 2026 | $0.01 | +$0.13 |
| Q4 2025 | $0.01 | +$0.18 |
| Q3 2025 | $0.01 | +$0.28 |
| Q2 2025 | -$0.07 | +$0.32 |
| Q1 2025 | -$0.12 | +$0.35 |
| Q4 2024 | -$0.17 | +$0.37 |
WRBY's earnings per share have climbed steadily: $0.05 over the past year, about five times what it earned the year before, and higher year over year every quarter since early 2023.
NVO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $11.7B | +2.1% |
| Q1 2026 | $14.4B | +24% |
| Q4 2025 | $11.8B | -7.6% |
| Q3 2025 | $11.1B | +5.1% |
| Q2 2025 | $11.4B | +13% |
| Q1 2025 | $11.6B | +19% |
| Q4 2024 | $12.7B | +30% |
| Q3 2024 | $10.6B | +21% |
NVO's revenue is growing: $11.7B last quarter, up 2.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 34% | -9 points |
| Q1 2026 | 62% | +12 points |
| Q4 2025 | 40% | -2.8 points |
| Q3 2025 | 32% | -16 points |
| Q2 2025 | 44% | +5.4 points |
| Q1 2025 | 50% | +1 points |
| Q4 2024 | 43% | +2.2 points |
| Q3 2024 | 47% | +1.6 points |
NVO has the edge over WRBY on profitability, with a higher operating margin.
WRBY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $244.7M | +10% |
| Q2 2026 | $235.5M | +9.8% |
| Q1 2026 | $242.4M | +8.3% |
| Q4 2025 | $212M | +11% |
| Q3 2025 | $221.7M | +15% |
| Q2 2025 | $214.5M | +14% |
| Q1 2025 | $223.8M | +12% |
| Q4 2024 | $190.6M | +18% |
WRBY's revenue has grown year over year every quarter since early 2021: $245M last quarter, up 10% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.4% | -0.2 points |
| Q2 2026 | 1.3% | +3.5 points |
| Q1 2026 | 0.7% | -0.4 points |
| Q4 2025 | -3.2% | +1.7 points |
| Q3 2025 | 1.6% | +5 points |
| Q2 2025 | -2.1% | +2.6 points |
| Q1 2025 | 1.1% | +3.7 points |
| Q4 2024 | -4.9% | +8.4 points |
WRBY's operating margin was 1.4% last quarter, about level with the same quarter a year ago.
NVO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $6.3B | +73% |
| Q1 2026 | $1.8B | +20% |
| Q4 2025 | -$5.4B | -$4.7B |
| Q3 2025 | $4.6B | -2.1% |
| Q2 2025 | $3.6B | -34% |
| Q1 2025 | $1.5B | +89% |
| Q4 2024 | -$632.6M | +$390.5M |
| Q3 2024 | $4.7B | +3.3% |
NVO has the edge over WRBY on cash flow, with more consistent year-over-year improvement.
WRBY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$2M | -$459K |
| Q2 2026 | $6.8M | -72% |
| Q1 2026 | $8.4M | -37% |
| Q4 2025 | $8.1M | +271% |
| Q3 2025 | -$1.5M | -112% |
| Q2 2025 | $23.9M | +71% |
| Q1 2025 | $13.2M | +141% |
| Q4 2024 | $2.2M | +2282% |
WRBY usually generates cash, though not every quarter: the latest was −$2M, but it generated $21M over the past year.
NVO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -12.9M shares |
| 1 year | -0.2% | -11M shares |
| 3 years | -1.5% | -66.8M shares |
| 5 years | -3.8% | -177M shares |
| Available history | -6.5% | -311M shares |
NVO has the edge over WRBY on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $520M |
| Q1 2026 | $356.7M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $206.3M |
| Q4 2024 | $1.1B |
| Q3 2024 | $357.4M |
NVO spent $877M buying back its own shares over the past year, down 48% from the year before.
WRBY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +401K shares |
| 1 year | +0.6% | +741K shares |
| 3 years | +6.9% | +8.1M shares |
| 5 years | +101% | +63.3M shares |
WRBY has 126M diluted shares, up 0.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
| Q2 2021 | $2M |
| Q1 2021 | $6.1M |
| Q4 2020 | — |
NVO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.7x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.4x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
| Q3 2024 | -0.0x | Very low |
NVO's net debt is less than a year of its operating earnings (EBITDA).
WRBY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -5.1x | Net Cash |
| Q2 2026 | -5.3x | Net Cash |
| Q1 2026 | -6.3x | Net Cash |
| Q4 2025 | -6.4x | Net Cash |
| Q3 2025 | -6.7x | Net Cash |
| Q2 2025 | -9.3x | Net Cash |
| Q1 2025 | -10.6x | Net Cash |
| Q4 2024 | -16.1x | Net Cash |
WRBY has the edge over NVO on leverage, with a lower net debt burden relative to earnings.
NVO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.0 | Neutral |
| Stochastic | 27.0 | Neutral |
NVO's weekly RSI is 43 (neutral) and its Stochastic is 27 (neutral).
WRBY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.1 | Neutral |
| Stochastic | 40.8 | Neutral |
WRBY's weekly RSI is 53 (neutral) and its Stochastic is 41 (neutral).
NVO PE vs Healthcare Sector
| Metric | NVO | Sector median | Relative |
|---|---|---|---|
| PE | 10x | 26x | 60% below |
| PE % | 6 | 29 | 23 pts below |
NVO has the edge over WRBY on valuation relative to its sector.
WRBY PE vs Healthcare Sector
| Metric | WRBY | Sector median | Relative |
|---|---|---|---|
| PE | 535x | 26x | 1,968% above |
| PE % | 26 | 39 | 13 pts below |
WRBY is trading at 535x earnings, a 1968% premium to the Healthcare sector's median of 26x.
NVO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $39.2 | 3.7% above |
| 20 week MA | $43.9 | 7.4% below |
| 50 week MA | $45.3 | 10% below |
| 100 week MA | $56.3 | 28% below |
| 200 week MA | $80.7 | 50% below |
NVO has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 50% below its 200-week average.
WRBY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $25.6 | 4.3% above |
| 20 week MA | $25.9 | 3.3% above |
| 50 week MA | $25.2 | 6.2% above |
| 100 week MA | $23.7 | 13% above |
| 200 week MA | $18.9 | 42% above |
WRBY has the edge over NVO on trend strength, trading above more of its moving averages.
NVO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $29.1 | $34.7 | +19% |
| 2021 | $34.7 | $54.2 | +56% |
| 2022 | $54.2 | $67.0 | +24% |
| 2023 | $67.0 | $103.5 | +54% |
| 2024 | $103.5 | $87.4 | -16% |
| 2025 | $87.4 | $52.4 | -40% |
| 2026 YTD | $52.4 | $40.7 | -22% |
NVO has finished higher in four of the last six years, two of them by more than 50%. It's down 22% so far in 2026.
WRBY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $53.7 | $47.5 | -12% |
| 2022 | $47.5 | $13.5 | -72% |
| 2023 | $13.5 | $14.1 | +4.2% |
| 2024 | $14.1 | $24.4 | +73% |
| 2025 | $24.4 | $24.2 | -1% |
| 2026 YTD | $24.2 | $26.7 | +11% |
WRBY has the edge over NVO on returns for 2026, with the stronger performance.